Clinical Trials Browser

AK002 × Clear all

NCT02808793 2019-03-13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Phase 1 Completed

Mastocytosis, Mastocytosis, Systemic